Eccrine Epithelioma: Case Report

Cottel, Willis I.

doi:10.1111/j.1524-4725.1982.tb00319.x

Cited by 22 publications

(22 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Management consists of surgical excision, as the tumors are reported to be radio‐resistant 106,108,109 . Several authors propose Mohs micrographic surgery to be the preferred method of excision due to the tumor's propensity for deep extension and perineural invasion 110–112 …”

Section: Cutaneous Tumors With Perineural Involvementmentioning

confidence: 99%

Perineural Invasion of Cutaneous Malignancies

et al. 2001

View full text Add to dashboard Cite

show abstract

Section: Cutaneous Tumors With Perineural Involvementmentioning

confidence: 99%

Perineural Invasion of Cutaneous Malignancies

et al. 2001

View full text Add to dashboard Cite

show abstract

“…Mohs micrographic surgery (MMS) has often been recommended because the method can theoretically trace out the microscopic ramifications of the tumor. However, since the histologic differential diagnoses may also include morphemic basal cell carcinoma, squamous cell carcinoma, desmoplastic trichoepithelioma, syringomatous eccrine carcinoma, 2,3 and others, there is some controversy concerning the reliability of MMS for MAC, especially in the absence of long‐term follow‐up data. Here we present 13 cases of MAC treated by MMS and provide long‐term, 5‐year follow‐up data 4 …”

mentioning

confidence: 99%

Microcystic Adnexal Carcinoma: Report of 13 Cases and Review of the Literature

Snow

Madjar²,

Hardy³

et al. 2001

Dermatol Surg

125

View full text Add to dashboard Cite

We update the medical literature with 13 MAC cases treated by MMS. To our knowledge there have been 148 cases of MAC reported in the world literature. Including our series, there have been 73 cases of MAC treated with MMS. There were only four treatment failures. Regional and/or distant metastasis from MAC is rare, with only one reported death. Following MMS, the 2-year success rate was 89.7% (35 of 39). The accumulated data continue to confirm that when MAC is discovered early and is readily accessible to excision by MMS and other subspecialty support, a favorable outcome can be expected.

show abstract

“…choice for management of such a sweat-gland tumor since this type of carcinoma typically features a poor response to chemotherapy and radiotherapy. [1] Recent studies suggest that Mohs' micrographic surgery is the method of choice [4][5][6] …”

Section: Discussionmentioning

confidence: 99%

Primary cutaneous sweat gland carcinoma

Wang

Zheng

et al. 2014

J Can Res Ther

View full text Add to dashboard Cite

Primary cutaneous sweat gland carcinoma is a rare neoplasm of malignant sweat gland lesions. It is characterized clinically with non-symptomatic, slow-growing nodules. We report the case of a patient with cutaneous sweat gland carcinoma with local recurrence and metastasis to the lung that was treated with surgical resection therapy and chemotherapy. The initial neoplasm was excised but biopsy was not performed. The tumor then recurred 7 years later, was re-excised, biopsy was performed, and diagnosed as a low-grade hidradenocarcinoma. We presented a very good result of chemotherapy in the treatment of this rare malignant disease. It demonstrates that adjunct chemotherapy is effective to control the condition of malignant sweat-gland carcinomas patient.

show abstract

Eccrine Epithelioma: Case Report

Cited by 22 publications

References 6 publications

Perineural Invasion of Cutaneous Malignancies

Perineural Invasion of Cutaneous Malignancies

Microcystic Adnexal Carcinoma: Report of 13 Cases and Review of the Literature

Primary cutaneous sweat gland carcinoma

Contact Info

Product

Resources

About